TrialDiabetes, obesity & metabolism2011

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.

S Del Prato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.